Meadowbrook Advisors Group’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229K Sell
1,939
-860
-31% -$99.3K 0.12% 159
2026
Q1
$334K Sell
2,799
-78
-3% -$10.2K 0.2% 104
2025
Q4
$392K Buy
+2,877
New +$414K 0.22% 93

Other funds holding XYL

Meadowbrook Advisors Group's XYL Position: Q2 2026 in Review

Meadowbrook Advisors Group reduced its Xylem (XYL) stake by 31% in Q2 2026, selling an estimated $99.3K and leaving 1,939 shares worth $229K. The position accounts for 0.12% of the portfolio, ranked #159.

Meadowbrook Advisors Group first reported a position in XYL in Q4 2025 and has held it in 3 quarters since. The position peaked at $392K in Q4 2025. 1,088 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Meadowbrook Advisors Group held 1,939 shares of Xylem worth $229K as of Q2 2026.
  • Meadowbrook Advisors Group sold 860 Xylem shares in Q2 2026, an estimated $99.3K.
  • Xylem made up 0.12% of Meadowbrook Advisors Group's portfolio in Q2 2026, its #159 holding.
  • Meadowbrook Advisors Group first reported a position in Xylem in Q4 2025 and has held it in 3 quarters since.
  • Meadowbrook Advisors Group's Xylem position peaked at $392K in Q4 2025.
  • 1,088 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Meadowbrook Advisors Group's 13F filing for Q2 2026, filed 7 Aug 2026.